{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T06:48:56Z","timestamp":1782283736199,"version":"3.54.5"},"reference-count":73,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100007059","name":"Univerzita Palack\u00e9ho v Olomouci","doi-asserted-by":"publisher","award":["IGA_PrF_2020_023"],"award-info":[{"award-number":["IGA_PrF_2020_023"]}],"id":[{"id":"10.13039\/501100007059","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001823","name":"Ministerstvo \u0160kolstv\u00ed, Ml\u00e1de\u017ee a T\u011blov\u00fdchovy","doi-asserted-by":"publisher","award":["LO1305"],"award-info":[{"award-number":["LO1305"]}],"id":[{"id":"10.13039\/501100001823","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007594","name":"Univerzita Komensk\u00e9ho v Bratislave","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007594","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015352","name":"Farmaceutick\u00e1 fakulta, Univerzita Komensk\u00e9ho v Bratislave","doi-asserted-by":"publisher","award":["FaF UK\/26\/2019"],"award-info":[{"award-number":["FaF UK\/26\/2019"]}],"id":[{"id":"10.13039\/100015352","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.bioorg.2020.104060","type":"journal-article","created":{"date-parts":[[2020,6,30]],"date-time":"2020-06-30T19:28:55Z","timestamp":1593545335000},"page":"104060","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Insight into antimicrobial activity of substituted phenylcarbamoyloxypiperazinylpropanols"],"prefix":"10.1016","volume":"102","author":[{"given":"Sarka","family":"Pospisilova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan","family":"Malik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jana","family":"Curillova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hana","family":"Michnova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucie","family":"Cerna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tereza","family":"Padrtova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Hosek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Pecher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alois","family":"Cizek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josef","family":"Jampilek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2020.104060_b0005","unstructured":"No Time To Wait: Securing the Future from Drug-Resistant Infections, WHO \u2013 Interagency Coordination Group on Antimicrobial Resistance, https:\/\/www.who.int\/antimicrobial-resistance\/interagency-coordination-group\/IACG_final_report_EN.pdf?ua=1 (accessed 30 March 2020)."},{"key":"10.1016\/j.bioorg.2020.104060_b0010","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1016\/j.drudis.2019.08.004","article-title":"Superbugs but no drugs: steps in averting a post-antibiotic era","volume":"24","author":"Hamad","year":"2019","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.bioorg.2020.104060_b0015","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1517\/17460441.2010.508069","article-title":"Dual-acting hybrid antibiotics: a promising strategy to combat bacterial resistance","volume":"5","author":"Pokrovskaya","year":"2010","journal-title":"Expert Opin. Drug Discov."},{"key":"10.1016\/j.bioorg.2020.104060_b0020","doi-asserted-by":"crossref","first-page":"2428","DOI":"10.1016\/j.bmcl.2012.02.019","article-title":"Structure aided design of chimeric antibiotics","volume":"22","author":"Karoli","year":"2012","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2020.104060_b0025","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1016\/j.ejmech.2010.01.024","article-title":"Novel quinoline and naphthalene derivatives as potent antimycobacterial agents","volume":"45","author":"Upadhayaya","year":"2010","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2020.104060_b0030","first-page":"446","article-title":"Synthesis of some novel piperazine salts and their antimicrobial property against Escherichia coli and Bacillus subtilis","volume":"2","author":"Bishnoi","year":"2010","journal-title":"Der Pharma Chem."},{"key":"10.1016\/j.bioorg.2020.104060_b0035","first-page":"196","article-title":"Synthesis and in vitro antibacterial activity of N-alkyl and N-aryl piperazine derivatives","volume":"50","author":"Singh","year":"2011","journal-title":"Ind. J. Chem. B"},{"key":"10.1016\/j.bioorg.2020.104060_b0040","doi-asserted-by":"crossref","first-page":"15","DOI":"10.2298\/ABS1201015N","article-title":"Investigation of antibacterial activity of cinnamyl derivatives of arylpiperazine","volume":"64","author":"Novakovic","year":"2012","journal-title":"Arch. Biol. Sci."},{"key":"10.1016\/j.bioorg.2020.104060_b0045","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.3390\/molecules21101274","article-title":"The structure\u2013antimicrobial activity relationships of promising class of the compounds containing N-arylpiperazine scaffold","volume":"21","author":"Malik","year":"2016","journal-title":"Molecules"},{"key":"10.1016\/j.bioorg.2020.104060_b0050","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.3390\/molecules22122100","article-title":"Synthesis and in vitro antimycobacterial activity of novel N-arylpiperazines containing an ethane-1,2-diyl connecting chain","volume":"22","author":"Gonec","year":"2017","journal-title":"Molecules"},{"key":"10.1016\/j.bioorg.2020.104060_b0055","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1080\/1062936X.2018.1517278","article-title":"Probability-driven 3D pharmacophore mapping of antimycobacterial potential of hybrid molecules combining phenylcarbamoyloxy and N-arylpiperazine fragments","volume":"29","author":"Bak","year":"2018","journal-title":"SAR QSAR Environ. Res."},{"key":"10.1016\/j.bioorg.2020.104060_b0060","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.2174\/1389203720666190913114041","article-title":"Activity of N-phenylpiperazine derivatives against bacterial and fungal pathogens","volume":"20","author":"Pospisilova","year":"2019","journal-title":"Curr. Protein Pept. Sci."},{"key":"10.1016\/j.bioorg.2020.104060_b0065","doi-asserted-by":"crossref","first-page":"713","DOI":"10.3906\/kim-1811-41","article-title":"Synthesis and antimicrobial activity of 1-(benzo[b]thiophen-4-yl)-4-(2-(oxo, hydroxyl, and fluoro)-2-phenylethyl) piperazine and 1-(benzo[d]isothiazole-3-yl)-4-(2-(oxo, hydroxy, and fluoro)-2-phenylethyl) piperazine derivatives","volume":"43","author":"Mishra","year":"2019","journal-title":"Turk. J. Chem."},{"key":"10.1016\/j.bioorg.2020.104060_b0070","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.ejmech.2011.11.022","article-title":"New N-methylpiperazinyl derivatives of bicyclic antiprotozoal compounds","volume":"47","author":"Faist","year":"2012","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2020.104060_b0075","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.ejmech.2017.08.017","article-title":"Search of new structural scaffolds for sphingosine kinase 1 inhibitors","volume":"139","author":"Vettorazzi","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2020.104060_b0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2019.103125","article-title":"Searching new structural scaffolds for BRAF inhibitors. Integrative study using theoretical and experimental techniques","volume":"91","author":"Campos","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2020.104060_b0085","doi-asserted-by":"crossref","first-page":"528","DOI":"10.2174\/1871520619666190121155651","article-title":"Synthesis of new N1-arylpiperazine substituted xanthine derivatives and evaluation of their antioxidant and cytotoxic effects","volume":"19","author":"Andonova","year":"2019","journal-title":"Anticancer Agents Med Chem."},{"key":"10.1016\/j.bioorg.2020.104060_b0090","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1016\/S0960-894X(02)00322-0","article-title":"Novel diphenylalkyl piperazine derivatives with dual calcium antagonistic and antioxidative activities","volume":"12","author":"Kimura","year":"2002","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2020.104060_b0095","doi-asserted-by":"crossref","first-page":"2764","DOI":"10.1016\/j.bmc.2019.05.004","article-title":"Design, synthesis and biological evaluation of isochroman-4-one hybrids bearing piperazine moiety as antihypertensive agent candidates","volume":"27","author":"Xie","year":"2019","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2020.104060_b0100","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1007\/s00210-019-01620-7","article-title":"New arylpiperazine derivatives with antidepressant-like activity containing isonicotinic and picolinic nuclei: evidence for serotonergic system involvement","volume":"392","author":"Kedzierska","year":"2019","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"key":"10.1016\/j.bioorg.2020.104060_b0105","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/j.bmcl.2018.02.003","article-title":"MF-8, a novel promising arylpiperazine-hydantoin based 5-HT7 receptor antagonist: In vitro drug-likeness studies and in vivo pharmacological evaluation","volume":"28","author":"Latacz","year":"2018","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2020.104060_b0110","doi-asserted-by":"crossref","first-page":"2895","DOI":"10.1021\/jm501371s","article-title":"Organic carbamates in drug design and medicinal chemistry","volume":"58","author":"Ghosh","year":"2015","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2020.104060_b0115","doi-asserted-by":"crossref","first-page":"4564","DOI":"10.1016\/j.bmcl.2011.05.118","article-title":"Photosynthesis-inhibiting efficiency of 4-chloro-2-(chlorophenylcarbamoyl)phenyl alkylcarbamates","volume":"21","author":"Imramovsky","year":"2011","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2020.104060_b0120","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.ejps.2015.06.009","article-title":"Salicylanilide carbamates: Promising antibacterial agents with high in vitro activity against methicillin-resistant Staphylococcus aureus (MRSA)","volume":"77","author":"Zadrazilova","year":"2015","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.bioorg.2020.104060_b0125","doi-asserted-by":"crossref","first-page":"528","DOI":"10.2174\/1570180813666160923105636","article-title":"Synthesis of novel 4-(dimethylaminoalkyl) piperazine-1-carbodithioate derivatives as cholinesterase inhibitors","volume":"14","author":"Cevik","year":"2017","journal-title":"Lett. Drug Des. Discov."},{"key":"10.1016\/j.bioorg.2020.104060_b0130","doi-asserted-by":"crossref","first-page":"2584","DOI":"10.1016\/j.bmcl.2006.02.048","article-title":"Synthesis of new and potent analogues of anti-tuberculosis agent 5-nitro-furan-2-carboxylic acid 4-(4-benzyl-piperazin-1-yl)-benzylamide with improved bioavailability","volume":"16","author":"Tangallapally","year":"2006","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2020.104060_b0135","doi-asserted-by":"crossref","first-page":"4035","DOI":"10.1016\/j.bmc.2008.01.023","article-title":"Design, synthesis and biological evaluation of piperazine analogues as CB1 cannabinoid receptor ligands","volume":"16","author":"Song","year":"2008","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2020.104060_b0140","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.ejmech.2008.04.007","article-title":"Synthesis, optimization and structure\u2013activity relationships of 3,5-disubstituted isoxazolines as new anti-tuberculosis agents","volume":"44","author":"Sun","year":"2009","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2020.104060_b0145","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1016\/j.bmc.2013.01.050","article-title":"Design, structure\u2013activity relationship and in vivo efficacy of piperazine analogues of fenarimol as inhibitors of Trypanosoma cruzi","volume":"21","author":"Keenan","year":"2013","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2020.104060_b0150","doi-asserted-by":"crossref","first-page":"339","DOI":"10.3892\/mmr.2015.4561","article-title":"Newly synthesized podophyllotoxin derivative, LJ12, induces apoptosis and mitotic catastrophe in non-small cell lung cancer cells in vitro","volume":"13","author":"Hui","year":"2016","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.bioorg.2020.104060_b0155","doi-asserted-by":"crossref","first-page":"159","DOI":"10.17344\/acsi.2016.2986","article-title":"Synthesis of some unique carbamate derivatives bearing 2-furoyl-1-piperazine as valuable therapeutic agents","volume":"64","author":"Abbasi","year":"2017","journal-title":"Acta Chim. Slov."},{"key":"10.1016\/j.bioorg.2020.104060_b0160","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1021\/jm9911276","article-title":"Structure-activity relationships in platelet-activating factor (PAF). 10. From PAF antagonism to inhibition of HIV-1 replication","volume":"43","author":"Serradji","year":"2000","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2020.104060_b0165","first-page":"2759","article-title":"The synthesis and in vitro screening of the 2-\/3-alkoxyphenylcarbamic acid derivatives containing a 4'-(2'-fluorophenyl)piperazin-1'-yl moiety against some non-tuberculous mycobacterial strains","volume":"26","author":"Malik","year":"2017","journal-title":"Fresen. Environ. Bull."},{"key":"10.1016\/j.bioorg.2020.104060_b0170","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/BF02879011","article-title":"Antimicrobial efficiency of \u03c9-piperidinoethyl esters of n-alkoxyphenylcarbamic acid","volume":"21","author":"Mlynarcik","year":"1976","journal-title":"Folia Microbiol."},{"key":"10.1016\/j.bioorg.2020.104060_b0175","first-page":"575","article-title":"Antimikrobielle Eingenschafften einiger basischen Ethylester von Alkoxyphenylcarbamins\u00e4uren (In German)","volume":"34","author":"Mlynarcik","year":"1979","journal-title":"Pharmazie"},{"key":"10.1016\/j.bioorg.2020.104060_b0180","first-page":"442","article-title":"Beziehung zwischen antimikrobieller Wirkung auf Staphylococcus aureus und den Konstanten \u03c3 und \u03c0 einiger p-substituierter Derivate der Phenylcarbamids\u00e4ure (In German)","volume":"41","author":"Cizmarik","year":"1986","journal-title":"Pharmazie"},{"key":"10.1016\/j.bioorg.2020.104060_b0185","first-page":"345","article-title":"A correlation between the antimicrobial activity to Staphylococcus aureus and selected physico-chemical parameters in the series of hydrochlorides of piperidinoethylesters of alkoxy-substituted phenylcarbamic acid (In Slovak)","volume":"36","author":"Cizmarik","year":"1987","journal-title":"\u010ceskoslov. Farm."},{"key":"10.1016\/j.bioorg.2020.104060_b0190","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.bmc.2012.10.053","article-title":"Search for new tools to combat Gram-negative resistant bacteria among amine derivatives of 5-arylidenehydantoin","volume":"21","author":"Handzlik","year":"2013","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2020.104060_b0195","doi-asserted-by":"crossref","first-page":"5807","DOI":"10.1016\/j.ejmech.2011.09.032","article-title":"Amine-alkyl derivatives of hydantoin: new tool to combat resistant bacteria","volume":"46","author":"Handzlik","year":"2011","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2020.104060_b0200","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1007\/BF02876602","article-title":"Antimicrobial effects of heptacaine and some intermediary products obtained during its synthesis","volume":"23","author":"Cizmarik","year":"1978","journal-title":"Folia Microbiol."},{"key":"10.1016\/j.bioorg.2020.104060_b0205","first-page":"362","article-title":"Biological evaluation of 10-(diphenylmethylene)-4-azatricyclo[5.2.1.02,6]dec-8-ene-3,5-dione derivatives","volume":"4","author":"Stefanska","year":"2009","journal-title":"Cent. Eur. J. Biol."},{"key":"10.1016\/j.bioorg.2020.104060_b0210","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.farmac.2004.11.003","article-title":"Synthesis and in vitro pharmacological activity of oxypropanol analogs of labetalol","volume":"60","author":"Brizzi","year":"2005","journal-title":"Farmaco"},{"key":"10.1016\/j.bioorg.2020.104060_b0215","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/j.farmac.2005.07.008","article-title":"Synthesis of 1,2-benzisothiazolyloxypropanolamine derivatives and investigation of their activity at \u03b2-adrenoceptors","volume":"60","author":"Morini","year":"2005","journal-title":"Farmaco"},{"key":"10.1016\/j.bioorg.2020.104060_b0220","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-409X(96)00423-1","article-title":"Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings","volume":"23","author":"Lipinski","year":"1997","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.bioorg.2020.104060_b0225","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1517\/17460441.2016.1110142","article-title":"Potential of agricultural fungicides for antifungal drug discovery","volume":"11","author":"Jampilek","year":"2016","journal-title":"Expert Opin. Drug Dis."},{"key":"10.1016\/j.bioorg.2020.104060_b0230","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1758-2946-1-8","article-title":"Estimation of synthetic accessibility score of drug-like molecules based on molecular complexity and fragment contributions","volume":"1","author":"Ertl","year":"2009","journal-title":"J. Cheminform."},{"key":"10.1016\/j.bioorg.2020.104060_b0235","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1111\/1462-2920.12213","article-title":"American crows as carriers of vancomycin-resistant enterococci with vanA gene","volume":"16","author":"Oravcova","year":"2014","journal-title":"Environ. Microbiol."},{"key":"10.1016\/j.bioorg.2020.104060_b0240","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1000855","article-title":"A timescale for evolution, population expansion, and spatial spread of an emerging clone of methicillin-resistant Staphylococcus aureus","volume":"6","author":"Nubel","year":"2010","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.bioorg.2020.104060_b0245","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.diagmicrobio.2010.11.018","article-title":"In vitro biofilm formation and bactericidal activities of methicillin-resistant Staphylococcus aureus clones prevalent in Korea","volume":"70","author":"Cha","year":"2011","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"10.1016\/j.bioorg.2020.104060_b0250","doi-asserted-by":"crossref","unstructured":"L. Yet, Privileged Structures in Drug Discovery: Medicinal Chemistry and Synthesis. John Wiley & Sons, Inc. Hoboken, NJ, USA, 2018. doi: 10.1002\/9781118686263.","DOI":"10.1002\/9781118686263"},{"key":"10.1016\/j.bioorg.2020.104060_b0255","doi-asserted-by":"crossref","first-page":"6574","DOI":"10.1016\/j.bmc.2013.08.029","article-title":"New derivatives of salicylamides: Preparation and antimicrobial activity against various bacterial species","volume":"21","author":"Pauk","year":"2013","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2020.104060_b0260","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/349534","article-title":"In vitro bactericidal activity of 4- and 5-chloro-2-hydroxy-N-[1-oxo-1-(phenylamino)alkan-2-yl]benzamides against MRSA","volume":"2015","author":"Zadrazilova","year":"2015","journal-title":"BioMed Res. Int."},{"key":"10.1016\/j.bioorg.2020.104060_b0265","doi-asserted-by":"crossref","first-page":"215","DOI":"10.3329\/dujps.v13i2.21903","article-title":"In vitro antimicrobial evaluation of ortho-\/meta-alkoxyphenylcarbamic acid esters containing 4-(pyrimidin-2-yl) piperazin-1-yl moiety","volume":"13","author":"Malik","year":"2014","journal-title":"Dhaka Univ. J. Pharm. Sci."},{"key":"10.1016\/j.bioorg.2020.104060_b0270","doi-asserted-by":"crossref","first-page":"231","DOI":"10.3329\/dujps.v14i2.28515","article-title":"In vitro evaluation of 2-\/3-alkoxyphenylcarbamic acid esters containing N-arylpiperazine moiety against some nontuberculous mycobacteria","volume":"14","author":"Malik","year":"2015","journal-title":"Dhaka Univ. J. Pharm. Sci."},{"issue":"36","key":"10.1016\/j.bioorg.2020.104060_b0275","first-page":"45","article-title":"The potential antituberculotics of the series of 2-hydroxy-3-(4-phenylpiperazin-l-yl)-propylphenyl-carbamates","volume":"35","author":"Waisser","year":"2007","journal-title":"Folia Pharm. Univ. Carol."},{"key":"10.1016\/j.bioorg.2020.104060_b0280","series-title":"Antimicrobial Susceptibility Testing Protocols","author":"Schwalbe","year":"2007"},{"key":"10.1016\/j.bioorg.2020.104060_b0285","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/S0732-8893(02)00473-X","article-title":"Comparison of methods of interpretation of checkerboard synergy testing","volume":"44","author":"Bonapace","year":"2002","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"10.1016\/j.bioorg.2020.104060_b0290","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1021\/bi5000564","article-title":"Mechanism of quinolone action and resistance","volume":"53","author":"Aldred","year":"2014","journal-title":"Biochemistry"},{"key":"10.1016\/j.bioorg.2020.104060_b0295","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2741\/culebras","article-title":"Aminoglycoside resistance mediated by the bifunctional enzyme 6\u2032-N-aminoglycoside acetyltransferase-2\u2033-O-aminoglycoside phosphotransferase","volume":"4","author":"Culebras","year":"1999","journal-title":"Front. Biosci."},{"key":"10.1016\/j.bioorg.2020.104060_b0300","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1002\/cmdc.201100346","article-title":"Inhibition of aminoglycoside-deactivating enzymes APH (3\u2032)-IIIa and AAC (6\u2032)-II by amphiphilic paromomycin O2\u2033-ether analogues","volume":"6","author":"Szychowski","year":"2011","journal-title":"ChemMedChem"},{"key":"10.1016\/j.bioorg.2020.104060_b0305","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1128\/CMR.13.4.686","article-title":"Vancomycin-resistant enterococci","volume":"13","author":"Cetinkaya","year":"2000","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.bioorg.2020.104060_b0310","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1248\/bpb.29.443","article-title":"Synergistic effect of [10]-gingerol and aminoglycosides against vancomycin-resistant enterococci (VRE)","volume":"29","author":"Nagoshi","year":"2006","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.bioorg.2020.104060_b0315","first-page":"207","article-title":"Staphylococcal biofilms","volume":"322","author":"Otto","year":"2008","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"10.1016\/j.bioorg.2020.104060_b0320","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.jep.2010.04.025","article-title":"Eugenol (an essential oil of clove) acts as an antibacterial agent against Salmonella typhi by disrupting the cellular membrane","volume":"130","author":"Devi","year":"2010","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.bioorg.2020.104060_b0325","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1128\/AAC.19.4.578","article-title":"Outer membrane permeability barrier disruption by polymyxinin polymyxin-susceptible and-resistant Salmonella typhimurium","volume":"19","author":"Vaara","year":"1981","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.bioorg.2020.104060_b0330","first-page":"1","article-title":"Envelope structures of gram-positive bacteria","volume":"404","author":"Rajagopal","year":"2017","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"10.1016\/j.bioorg.2020.104060_b0335","doi-asserted-by":"crossref","first-page":"2312","DOI":"10.1128\/AAC.01682-08","article-title":"Analysis of cell membrane characteristics of in vitro-selected daptomycin-resistant strains of methicillin-resistant Staphylococcus aureus","volume":"53","author":"Mishra","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.bioorg.2020.104060_b0340","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0043958","article-title":"Daptomycin resistance in enterococci is associated with distinct alterations of cell membrane phospholipid content","volume":"7","author":"Mishra","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.bioorg.2020.104060_b0345","doi-asserted-by":"crossref","first-page":"e00281","DOI":"10.1128\/mBio.00281-13","article-title":"Daptomycin-resistant Enterococcus faecalis diverts the antibiotic molecule from the division septum and remodels cell membrane phospholipids","volume":"4","author":"Tran","year":"2013","journal-title":"MBio"},{"key":"10.1016\/j.bioorg.2020.104060_b0350","unstructured":"Cell proliferation reagent WST-1. Roche Diagnostics GmbH, Mannheim, Germany. https:\/\/www.sigmaaldrich.com\/content\/dam\/sigma-aldrich\/docs\/Roche\/Bulletin\/1\/cellprorobul.pdf (accessed 24 January 2020)."},{"key":"10.1016\/j.bioorg.2020.104060_b0355","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1016\/j.bmc.2015.03.018","article-title":"Synthesis and antimycobacterial properties of ring-substituted 6-hydroxynaphthalene- 2-carboxanilides","volume":"23","author":"Kos","year":"2015","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2020.104060_b0360","unstructured":"Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing; The 8th Informational Supplement Document; CLSI: Wayne, PA, USA, 2012; M100-S22."},{"key":"10.1016\/j.bioorg.2020.104060_b0365","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.3390\/ijms19082318","article-title":"Synthesis and spectrum of biological activities of novel N-arylcinnamamides","volume":"19","author":"Pospisilova","year":"2018","journal-title":"Int. J. Mol. Sci."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206820313572?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206820313572?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T11:52:00Z","timestamp":1777463520000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206820313572"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":73,"alternative-id":["S0045206820313572"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2020.104060","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Insight into antimicrobial activity of substituted phenylcarbamoyloxypiperazinylpropanols","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2020.104060","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"104060"}}